Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56,222,082
-
Total 13F shares
-
44,645,769
-
Share change
-
+43,218
-
Total reported value
-
$3,422,654,573
-
Put/Call ratio
-
123%
-
Price per share
-
$76.69
-
Number of holders
-
292
-
Value change
-
-$7,846,781
-
Number of buys
-
169
-
Number of sells
-
117
Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q3 2019
As of 30 Sep 2019,
REPLIGEN CORP - COMMON STOCK (RGEN) was held by
292 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,645,769 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Invesco Ltd., STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, FRED ALGER MANAGEMENT, LLC, Conestoga Capital Advisors, LLC, FEDERATED INVESTORS INC /PA/, 12 West Capital Management LP, and MACQUARIE GROUP LTD.
This page lists
292
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.